Enveric Biosciences Inc (ENVB)
0.9114
-0.07
(-7.00%)
USD |
NASDAQ |
May 06, 16:00
0.9114
0.00 (0.00%)
After-Hours: 20:00
Enveric Biosciences Total Assets (Quarterly): 4.300M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 4.300M |
September 30, 2023 | 6.619M |
June 30, 2023 | 9.800M |
March 31, 2023 | 15.85M |
December 31, 2022 | 19.55M |
September 30, 2022 | 30.86M |
June 30, 2022 | 28.57M |
March 31, 2022 | 32.18M |
December 31, 2021 | 26.72M |
September 30, 2021 | 69.76M |
June 30, 2021 | 23.70M |
March 31, 2021 | 25.79M |
December 31, 2020 | 4.097M |
September 30, 2020 | 27.99M |
June 30, 2020 | 27.51M |
March 31, 2020 | 27.14M |
December 31, 2019 | 25.01M |
September 30, 2019 | 26.66M |
June 30, 2019 | 29.48M |
March 31, 2019 | 30.51M |
December 31, 2018 | 29.64M |
September 30, 2018 | 45.90M |
June 30, 2018 | 45.54M |
March 31, 2018 | 47.92M |
December 31, 2017 | 52.20M |
Date | Value |
---|---|
September 30, 2017 | 47.14M |
June 30, 2017 | 47.29M |
March 31, 2017 | 49.68M |
December 31, 2016 | 39.51M |
September 30, 2016 | 38.12M |
June 30, 2016 | 15.14M |
March 31, 2016 | 12.63M |
September 30, 2015 | 21.21M |
June 30, 2015 | 10.44M |
March 31, 2015 | 0.0039M |
December 31, 2014 | 0.0051M |
September 30, 2014 | 0.0091M |
June 30, 2014 | 0.012M |
March 31, 2014 | 0.0267M |
December 31, 2013 | 0.0045M |
September 30, 2013 | 0.0049M |
June 30, 2013 | 0.0066M |
March 31, 2013 | 0.0054M |
December 31, 2012 | 0.0056M |
September 30, 2012 | 0.0064M |
June 30, 2012 | 0.0064M |
March 31, 2012 | 0.0103M |
December 31, 2011 | 0.0225M |
September 30, 2011 | 0.0244M |
June 30, 2011 | 0.0081M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
4.097M
Minimum
Dec 2020
69.76M
Maximum
Sep 2021
24.29M
Average
26.66M
Median
Sep 2019
Total Assets (Quarterly) Benchmarks
Seelos Therapeutics Inc | 5.418M |
Societal CDMO Inc (DELISTED) | 153.47M |
Cardiff Oncology Inc | 74.04M |
BioVie Inc | 21.49M |
Adial Pharmaceuticals Inc | 4.737M |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 2.344M |
Shareholders Equity (Quarterly) | 1.956M |